The University of Southampton
University of Southampton Institutional Repository

DNA vaccination: a potential weapon against infection and cancer

DNA vaccination: a potential weapon against infection and cancer
DNA vaccination: a potential weapon against infection and cancer
DNA vaccination is a novel approach for inducing immunity against target antigens. It provides a direct link between identification of genes encoding these antigens and incorporation of the gene sequences into a vaccine vehicle. Identification of candidate genes is proceeding very rapidly both for infectious organisms and for cancer cells. One advantage is that DNA appears to activate all pathways of immunity, especially cytotoxic T-cell responses, which have been difficult to induce with protein vaccines. For viruses, including those which have caused problems for blood transfusion, DNA vaccination could be used for prevention. However, for chronic infection, or for cancer, vaccination will be performed in a therapeutic setting. For this situation, it is probable that immune-activating sequences will have to be included in the vaccine. The ease of manipulation of gene sequences, together with the increasing knowledge of the operation of the immune system, means that we now have the tools to take vaccines into the next exciting stage of development.
0042-9007
12-18
Stevenson, F.K.
ba803747-c0ac-409f-a9c2-b61fde009f8c
Rosenberg, W.
1a551f54-b4aa-42e0-a5e1-45c6a5232821
Stevenson, F.K.
ba803747-c0ac-409f-a9c2-b61fde009f8c
Rosenberg, W.
1a551f54-b4aa-42e0-a5e1-45c6a5232821

Stevenson, F.K. and Rosenberg, W. (2001) DNA vaccination: a potential weapon against infection and cancer. Vox Sanguinis, 80 (1), 12-18. (doi:10.1046/j.1423-0410.2001.00009.x).

Record type: Article

Abstract

DNA vaccination is a novel approach for inducing immunity against target antigens. It provides a direct link between identification of genes encoding these antigens and incorporation of the gene sequences into a vaccine vehicle. Identification of candidate genes is proceeding very rapidly both for infectious organisms and for cancer cells. One advantage is that DNA appears to activate all pathways of immunity, especially cytotoxic T-cell responses, which have been difficult to induce with protein vaccines. For viruses, including those which have caused problems for blood transfusion, DNA vaccination could be used for prevention. However, for chronic infection, or for cancer, vaccination will be performed in a therapeutic setting. For this situation, it is probable that immune-activating sequences will have to be included in the vaccine. The ease of manipulation of gene sequences, together with the increasing knowledge of the operation of the immune system, means that we now have the tools to take vaccines into the next exciting stage of development.

This record has no associated files available for download.

More information

Published date: 2001

Identifiers

Local EPrints ID: 26613
URI: http://eprints.soton.ac.uk/id/eprint/26613
ISSN: 0042-9007
PURE UUID: 49c18134-543e-4267-b692-82498a864719
ORCID for F.K. Stevenson: ORCID iD orcid.org/0000-0002-0933-5021

Catalogue record

Date deposited: 24 Apr 2006
Last modified: 16 Mar 2024 02:54

Export record

Altmetrics

Contributors

Author: F.K. Stevenson ORCID iD
Author: W. Rosenberg

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×